Texas Instruments Incorporated

TXN Technology Semiconductors

Texas Instruments Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $17.7 billion, up 13.0% from fiscal 2024.

Revenue
+27.7%
EPS
+76.7%
Free cash flow
+197.4%
Total debt
−3.50%

Quarter to September 2026, against a year earlier

275.98 2.17 −0.78%
Market cap
$254.2B
P/E
36.2×
Fwd P/E
33.2×
Dividend yield
2.05%
F-score
7/9
Altman Z
8.74
Beneish M
−2.67
Dividend safety
43/100

Texas Instruments Incorporated 10-K filed Feb 6, 2026

Fiscal year 2025 · Period ended Dec 31, 2025 · Filed · accepted 11:06 AM ET · Document on sec.gov · Filing index

Red flags

  • Impairment

    Texas Instruments Incorporated recorded a goodwill impairment of $32.0 million in fiscal 2025

    10-K filed · The filing · sec.gov

What changed

Item 1, Business, against the 10-K filed Feb 14, 2025: 3 added · 7 removed · 19 modified; 5 with only figures updated

  1. Modified

    The second element of our strategy to maximize free cash flow per share growth is disciplined allocation of capital. This spans how we select R&D projects, develop new capabilities, invest in manufacturing capacity or how we think about acquisitions and returning cash to our owners. Over a 10-year period from 20152016 to 20242025, we allocated $101109 billion, which reinforces the importance of discipline in capital allocation. The largest allocation over this period was to drive organic growth, which includes investments in R&D, sales and marketing, capital expenditures and working capital for inventory. In this period, we allocated about $2024 billion to capital expenditures. Our increased capital expenditures are to support future revenue growth, which will be a greater component of free cash flow per share growth going forward, as we are near completion of our six-year elevated capital expenditures cycle. Beyond that, we also allocated capital to dividends and share repurchases. Dividends are designed to appeal to a broad set of investors, and share repurchases are made with the goal of the accretive capture of future free cash flow for long-term investors. Lastly, for inorganic growth, we allocate toconsider acquisitions that meet our financial and strategic objectives.